Ignite Creation Date:
2025-12-24 @ 9:30 PM
Ignite Modification Date:
2026-01-01 @ 9:10 PM
Study NCT ID:
NCT05468632
Status:
COMPLETED
Last Update Posted:
2023-02-14
First Post:
2022-07-19
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study in North Macedonia Investigating Retrospective Data of Glucagon-like Peptide-1 (GLP-1) Participants With Type 2 Diabetes (T2D) in Real World Environment (RWE) Setting (MIRAGE)
Sponsor:
Novo Nordisk A/S
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-07-05
Start Date Type:
ACTUAL
Primary Completion Date:
2022-07-31
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-07-31
Completion Date Type:
ACTUAL
First Submit Date:
2022-07-19
First Submit QC Date:
None
Study First Post Date:
2022-07-21
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-02-10
Last Update Post Date:
2023-02-14
Last Update Post Date Type:
ACTUAL